April 17
–
April 21, 2023
Walter E. Washington Convention Center
Washington, DC
Add to Outlook Calendar
Several DCEG scientists will present their research at the 2023 International Papillomavirus Conference (IPVC) in Washington, DC and online from April 17-21. The full program can be found on the IPVC website.
Monday, April 17
Chaired Sessions
| Chair |
Session |
Time |
| Sarah S. Jackson |
Special Interest Satellite Symposium: HPV among transgender and gender diverse individuals: understanding the unique needs of the population |
8:30 - 10:00 AM EDT |
| Aimee R. Kreimer |
Public Health Workshop 01: HPV vaccination for prevention of cervical cancer |
1:30 - 3:00 PM EDT |
| Nicolas Wentzensen |
Public Health Workshop 02: Cervical Cancer Screening |
2:30 - 5:00 PM EDT |
Oral Presentations
| Presenter |
Session |
Presentation Title |
Time |
| Julia C. Gage |
Special Interest Satellite Symposium: Cervical Cancer Control in Latin America and the Caribbean |
A facilitation strategy for rapid, embedded engagement in HPV-based screening implementation planning in low- and middle-income countries (LMICs) |
11:45 AM EDT |
| Megan Clarke |
Clinical Workshop 01 |
New technologies for screening in developed and developing country settings |
1:30 - 1:50 PM EDT |
| Jaimie Z. Shing |
Public Health Workshop 01 |
HPV vaccination to prevent invasive cervical cancer |
2:04 - 2:22 PM EDT |
| Anil Chaturvedi |
Clinical Workshop 02 |
Current epidemiology of head and neck cancer |
3:45 - 4:00 PM EDT |
| Nicolas Wentzensen |
Public Health Workshop 02 |
Overview of epidemiologic methods: Sensitivity, specificity, predictive value, and risk-based triaging |
4:15 - 4:30 PM EDT |
Tuesday, April 18
Chaired Sessions
| Chair |
Session |
Time |
| John T. Schiller |
Clinical Workshop 04: New frontier in treatment of HPV-related cancers and pre-cancers |
8:30 - 10:00 AM EDT
|
| Lisa Mirabello |
Basic Science Workshop 04: HPV genomics and evolution |
10:30 AM - 12:00 PM EDT
|
Oral Presentations
| Presenter |
Session |
Presentation Title |
Time |
| Aimee R. Kreimer |
Clinical Workshop 03 |
HPV vaccine schedules - Latest updates |
9:00 - 9:15 AM EDT |
| Lisa Mirabello |
Basic Science Workshop 04 |
HPV genetic diversity, APOBEC mutagenesis |
11:30 AM - 12:00 PM EDT |
| John T. Schiller |
Clinical Workshop 04 |
Can we and should we treat HPV infection? |
11:30 AM - 12:00 PM EDT |
| Meredith Shiels |
Public Health Workshop 05 |
Evidence of inequity: Incidence and burden of cervical and other HPV-related cancers by ethnicity and race. |
2:00 - 2:15 PM EDT |
| Sarah S. Jackson |
Public Health Workshop 05 |
HPV vaccination, cancer prevention, and its associated challenges in SGM. |
3:00 - 3:15 PM EDT |
Wednesday, April 19
Panels
| Panelist |
Session |
Time |
| Jaimie Z. Shing |
Early Career Researchers Session 2: Publish or perish: The future of academic publishing |
7:00 - 8:00 AM EDT |
Chaired Sessions
| Chair |
Session |
Time |
| Jaimie Z. Shing |
Public Health Oral: Vaccination 1 |
9:45 - 10:45 AM EDT |
| Aimee R. Kreimer |
Special Interest Satellite Symposium: Current evidence for safety profile of the HPV Vaccines |
5:15 - 6:45 PM EDT |
Oral Presentation
| Presenter |
Session |
Presentation Title |
Time |
| Nicolas Wentzensen |
Special Interest Satellite Symposium: New guidelines for validation of HPV assays usable in cervical cancer screening |
FDA principles for validation of HPV assays in the USA |
10:21 - 10:33 AM EDT |
| Jaimie Z. Shing |
Public Health Oral: Vaccination 3 |
Differential HPV 16/18 vaccine efficacy against HPV13 by variants in the L1 sequence up to 11-years post-vaccination in the Costa Rica HPV Vaccine Trial |
4:35 - 4:45 PM EDT |
| Nicolas Wentzensen |
Clinical Science Oral |
Clinical performance of dual stain vs. cytology combined with extended genotyping in a large population of HPV-positive individuals: Implications for cervical cancer screening strategies |
6:35 - 6:45 PM EDT |
Poster Discussion
| Presenter |
Session |
Presentation Title |
Time |
| Cameron B. Haas |
Public Health 02 |
Anal test characteristics and disease detection among healthy women referred to high-resolution anoscopy: Findings from the Costa Rica Vaccine Trial Study |
9:15 - 9:20 AM EDT |
Meet the Poster Presenter
| Presenter |
Presentation Title |
Time |
| Aimee Koestler |
Whole-genome sequencing of 860 HPV45 cases and controls identifies genetic variants specifically associated with cervical glandular lesions |
4:45 - 5:15 PM EDT |
| Summer Harvey |
Associations of obesity with cervical cancer screening in the National Health Interview Survey. |
4:45 - 5:15 PM EDT |
| Cameron B. Haas |
Anal test characteristics and disease detection among healthy women referred to high-resolution anoscopy: Findings from the Costa Rica Vaccine Trial Study |
5:45 - 5:15 PM EDT |
Thursday, April 20
Chaired Sessions
| Chair |
Session |
Time |
| Lisa Mirabello |
Clinical Science Oral: Biomarkers for management of cervical lesions with an emphasis on methylation |
10:30 AM - 12:00 PM EDT |
Oral Presentation
| Presenter |
Session |
Presentation Title |
Time |
| Chase W. Nelson |
Basic Science Oral |
HPV16 genomics: The untold story of sublineage differences and carcinogenicity |
3:00 - 3:10 PM EDT |
| Lisa Mirabello |
Basic Science Oral |
HPV16 episomal multimers can form double-minute chromosomal structures and contribute to chromosome rearrangements |
3:30 - 3:40 PM EDT |
| Isabel Rodriguez |
Basic Science Oral |
A panel of 22 cervical cancer cell lines characterized by long-read DNA and RNA sequencing: Insights into HPV integration and transcription |
3:50 - 4:00 PM EDT |
Poster Discussion
| Presenter |
Session |
Presentation Title |
Time |
| Erica Stephens |
Public Health 03 |
Differences in HPV knowledge by race/ethnicity and educational attainment in the United States, Health Information National Trends Survey, 2016-2020 |
2:00 - 2:05 PM EDT |
Friday, April 21
Oral Presentations
| Presenter |
Session |
Presentation Title |
Time |
| Loretto J. Carvajal |
Public Health Oral |
Trends in incidence rates of head and neck squamous cell carcinomas in Costa Rica, with a special focus on human papillomavirus-related and-unrelated cancers |
8:50 - 9:00 AM EDT |
| Cameron B. Haas |
Public Health Oral |
Risk factors for anal high-grade squamous intraepithelial lesions among healthy women: Findings from the Costa Rica HPV Vaccine Trial Study |
9:00 - 9:10 AM EDT |
| Jose A. Jeronimo |
Clinical Science Oral |
Comparison of accuracy and reproducibility of colposcopic impression based on a single image versus a two-minute time series of colposcopic images |
9:10 - 9:20 AM EDT |
| Camryn M. Cohen |
Public Health Oral |
Racial and ethnic differences in cervical cancer incidence, survival and mortality by histologic subtype reveal profound disparities |
2:15 - 2:25 PM EDT |
Meet the Poster Presenter
| Presenter |
Presentation Title |
Time |
| Jaimie Z. Shing |
The incidence of HPV-associated cancers among disaggregated Asian American and Pacific Islander ethnographic regions and ethnicities: A population-based study in the United States |
9:30 - 10:00 AM EDT |
| Jennifer McGee-Avilla |
Multilevel determinants of Pap test receipt in women living with HIV: Individual, clinical, and healthcare level patterns of cervical cancer prevention modalities |
9:30 - 10:00 AM EDT |
| Sambit K. Mishra |
A longitudinal study of high-risk-HPV genomes reveals intra-host temporal changes to viral single nucleotide variants |
9:30 - 10:00 AM EDT |
| Erica Stephens |
Differences in HPV knowledge by race/ethnicity and educational attainment in the United States, Health Information National Trends Survey, 2016-2020 |
9:30 - 10:00 AM EDT |
Keynote Lecture
| Presenter |
Presentation Title |
Time |
| Douglas Lowy |
The future is now |
4:00 - 5:30 PM EDT |
